| Identifying protein features responsible for improved drug repurposing accuracies using the CANDO platform: Implications for drug design W Mangione, R Samudrala Molecules 24 (1), 167, 2019 | 24 | 2019 |
| Evaluating the performance of drug-repurposing technologies J Schuler, Z Falls, W Mangione, ML Hudson, L Bruggemann, ... Drug discovery today 27 (1), 49-64, 2022 | 23 | 2022 |
| Shotgun drug repurposing biotechnology to tackle epidemics and pandemics W Mangione, Z Falls, T Melendy, G Chopra, R Samudrala Drug Discovery Today 25 (7), 1126-1128, 2020 | 23 | 2020 |
| Exploration of interaction scoring criteria in the CANDO platform Z Falls, W Mangione, J Schuler, R Samudrala BMC research notes 12, 1-6, 2019 | 19 | 2019 |
| cando. py: Open source software for predictive bioanalytics of large scale drug–protein–disease data W Mangione, Z Falls, G Chopra, R Samudrala Journal of chemical information and modeling 60 (9), 4131-4136, 2020 | 17 | 2020 |
| Samudrala, R. cando. py: Open Source Software for Predictive Bioanalytics of Large Scale Drug–Protein–Disease Data W Mangione, Z Falls, G Chopra J. Chem. Inf. Model 60, 4131-4136, 2020 | 10 | 2020 |
| A deep-learning proteomic-scale approach for drug design B Overhoff, Z Falls, W Mangione, R Samudrala Pharmaceuticals 14 (12), 1277, 2021 | 7 | 2021 |
| Identifying protein features and pathways responsible for toxicity using machine learning and tox21: Implications for predictive toxicology L Moukheiber, W Mangione, M Moukheiber, S Maleki, Z Falls, M Gao, ... Molecules 27 (9), 3021, 2022 | 6 | 2022 |
| Foundations for a Realism-based Drug Repurposing Ontology. J Schuler, W Mangione, R Samudrala, W Ceusters ICBO, 1-8, 2019 | 6 | 2019 |
| Proteomic network analysis of bronchoalveolar lavage fluid in ex-smokers to discover implicated protein targets and novel drug treatments for chronic obstructive pulmonary disease MJ Mammen, C Tu, MC Morris, S Richman, W Mangione, Z Falls, J Qu, ... Pharmaceuticals 15 (5), 566, 2022 | 5 | 2022 |
| Optimal COVID-19 therapeutic candidate discovery using the CANDO platform W Mangione, Z Falls, R Samudrala Frontiers in Pharmacology 13, 970494, 2022 | 3 | 2022 |
| Effective holistic characterization of small molecule effects using heterogeneous biological networks W Mangione, Z Falls, R Samudrala Frontiers in Pharmacology 14, 1113007, 2023 | 2 | 2023 |
| Multiscale analysis and validation of effective drug combinations targeting driver kras mutations in non-small cell lung cancer L Bruggemann, Z Falls, W Mangione, SA Schwartz, S Battaglia, ... International Journal of Molecular Sciences 24 (2), 997, 2023 | 2 | 2023 |
| Coronavirus treatment compositions and methods R Samudrala, Z Falls, W Mangione US Patent App. 17/539,791, 2022 | 2 | 2022 |
| Comprehensive elucidation of small molecule therapeutic behavior using multitarget theory W Mangione State University of New York at Buffalo, 2022 | 1 | 2022 |
| Identifying protein features and pathways responsible for toxicity using machine learning, cando, and tox21 datasets: Implications for predictive toxicology L Moukheiber, W Mangione, S Maleki, Z Falls, M Gao, R Samudrala | 1 | 2021 |
